(Q32076763)

6 July 2017

title

Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia (English)

1 reference

familial hypercholesterolemia

6 July 2017

0 references

1 reference

1 reference

Hopkins PN

1

1 reference

6 July 2017

Stephenson S

2

1 reference

6 July 2017

Wu LL

3

1 reference

6 July 2017

Riley WA

4

1 reference

6 July 2017

Xin Y

5

1 reference

6 July 2017

Hunt SC

6

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

American Journal of Cardiology

6 July 2017

published in

1 reference

6 July 2017

volume

87

1 reference

6 July 2017

issue

5

1 reference

6 July 2017

page(s)

547-553

1 reference

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

NHLBI Family Heart Study: objectives and design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

High-resolution B-Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Effects of simvastatin on apoB metabolism and LDL subfraction distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Coronary artery disease in heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901429-6

10.1016/S0002-9149(00)01429-6

7 January 2021

Identifiers

DOI

1 reference

6 July 2017

1 reference